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Abstract
Background: Accurate laboratory diagnosis of malaria species in returning travelers is paramount
in the treatment of this potentially fatal infectious disease.
Materials and methods: A total of 466 blood specimens from returning travelers to Africa, Asia,
and South/Central America with suspected malaria infection were collected between 2007 and
2009 at the reference public health laboratory. These specimens were assessed by reference
microscopy, multipex real-time quantitative polymerase chain reaction (QPCR), and two rapid
diagnostic immuno-chromatographic tests (ICT) in a blinded manner. Key clinical laboratory
parameters such as limit of detection (LOD) analysis on clinical specimens by parasite stage, inter-
reader variability of ICTs, staffing implications, quality assurance and cost analysis were evaluated.
Results:  QPCR is the most analytically sensitive method (sensitivity 99.41%), followed by
CARESTART (sensitivity 88.24%), and BINAXNOW (sensitivity 86.47%) for the diagnosis of
malaria in returning travelers when compared to reference microscopy. However, microscopy was
unable to specifically identify Plasmodia spp. in 18 out of 170 positive samples by QPCR. Moreover,
the 17 samples that were negative by microscopy and positive by QPCR were also positive by ICTs.
Quality assurance was achieved for QPCR by exchanging a blinded proficiency panel with another
reference laboratory. The Kappa value of inter-reader variability among three readers for
BINAXNOW and CARESTART was calculated to be 0.872 and 0.898 respectively. Serial dilution
studies demonstrated that the QPCR cycle threshold correlates linearly with parasitemia (R2 =
0.9746) in a clinically relevant dynamic range and retains a LOD of 11 rDNA copies/μl for P.
falciparum, which was several log lower than reference microscopy and ICTs. LOD for QPCR is
affected not only by parasitemia but the parasite stage distribution of each clinical specimen. QPCR
was approximately 6-fold more costly than reference microscopy.
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Discussion: These data suggest that multiplex QPCR although more costly confers a significant
diagnostic advantage in terms of LOD compared to reference microscopy and ICTs for all four
species. Quality assurance of QPCR is essential to the maintenance of proficiency in the clinical
laboratory. ICTs showed good concordance between readers however lacked sensitivity for non-
falciparum species due to antigenic differences and low parasitemia.
Conclusion: Multiplex QPCR but not ICTs is an essential adjunct to microscopy in the reference
laboratory detection of malaria species specifically due to the superior LOD. ICTs are better suited
to the non-reference laboratory where lower specimen volumes challenge microscopy proficiency
in the non-endemic setting.
Background
The protozoan parasite Plasmodium which causes malaria
is a vector-borne infectious disease, estimated to infect
approximately 350-500 million and kill more than a mil-
lion people world wide every year [1]. There are five spe-
cies of the Plasmodium parasite that can infect humans: the
most virulent form of the disease is caused by Plasmodium
falciparum  and  Plasmodium knowlesi. Malaria caused by
Plasmodium vivax, Plasmodium ovale and Plasmodium malar-
iae, are more chronic disease in humans. In the past three
decades, with the globalization of economy and increas-
ing immigration frequency, there has been a significant
rise in the number of cases of imported malaria in non-
endemic, developed countries, such as Canada [2].
Toronto is a large urban center in Canada with high rates
of international travel and immigration and has recently
been subjected to waves of imported outbreaks, such as
SARS and swine H1N1 influenza [3].
Microscopic identification of malaria parasites relies on
examination of Giemsa-stained peripheral blood smears.
The sensitivity and specificity of this method are highly
affected by the staining techniques used and the skill level
of the microscopist [4-9]. Although light microscopy is
capable of defining parasite density, parasite stage, and
speciation, this method is labour-intensive and requires
well-trained experts at reference centres, not to mention
delays in specimen transport to such centres. In order to
make the diagnosis of malaria faster and simpler to per-
form, rapid tests have been developed based on antigen-
capture immuno-chromatographic tests (ICTs) as a valua-
ble adjunct to microscopy for the diagnosis of malaria [2].
The ICTs are useful for identifying P. falciparum infection,
but cannot be used to specifically identify non-P. falci-
parum species infections such as P. vivax, P. ovale, and P.
malariae [7].
In the past few decades, with the advent of technology in
molecular biology, new molecular methods have been
introduced, such as polymerase chain reaction (PCR) and
real-time quantitative polymerase chain reaction (QPCR).
These molecular methods can detect malaria parasites to
the species level by targeting the parasite DNA with good
analytical sensitivity and specificity in laboratory studies
[2,10-13]. QPCR in particular has been a successful
method for microbial detection from sterile sites with
excellent sensitivity and has the ability to be quantitative.
Many of the studies conducted to date seeking to validate
malaria molecular diagnostics are limited to the research
laboratory, but reports emphasizing the implementation
of these techniques in clinical laboratory setup have not
been adequately investigated in the past [14]. In the
present study, validation of QPCR as compared to refer-
ence microscopy and two different ICTs was performed
with particular attention to evaluating limits of detection,
quality assurance, cost, staffing, and implementation in
the clinical microbiology laboratory.
Materials and methods
Sample details
A total of 466 blood samples from individual patients
(returning travelers) with fever or a history of fever and
travel to a malaria-endemic area were tested by standard
Giemsa stain microscopy for Plasmodium  species detec-
tion. Summary statistics of patient clinical specimens are
summarized in Table 1. Blood specimens were collected at
Table 1: Summary of clinical specimens used in this study.
Patient characteristic Value
Male (%) 55.98
Female (%) 44.02
Average Age 31.16
Age range 1-90
Geometric Mean Parasitaemia (%) 0.095
Previous travel to Africa (%) 28.5
Previous travel to Asia (%) 42.3
Previous travel to Americas (%) 29.2Malaria Journal 2009, 8:284 http://www.malariajournal.com/content/8/1/284
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community and hospital laboratories in Ontario, Canada
and forwarded by courier the same day to the Public
Health Reference Laboratory in Toronto (PHL Toronto)
during the period May 2007 to January 2009. Infected
blood aliquots were banked in a malaria bio-repository (-
80°C monitored freezer) at PHL Toronto. Blood speci-
mens positive by microscopy as well as a subset negative
by microscopy were included in this study. Microscopy,
ICTs (BINAXNOW® MALARIA [Binax, Seattle, WA] and
CARESTART™ [Accessbio, Monmouth Junction, NJ])
detection and QPCR were performed in a blinded man-
ner.
Conventional microscopy
Microscopy of thick and thin Giemsa-stained smears was
performed according to standard methods by at least two
experienced microscopists for each specimen reported
here [15]. The parasitaemia is expressed as a percentage of
erythroyctes. Microscopy performed here is considered
reference microscopy and undergoes external quality
assurance as a participant of the Insitut National de Santé
Publique du Québec (INSPQ) blood parasitology pro-
gramme.
Immuno-chromatographic tests (ICT)
Two rapid ICTs (BINAXNOW® MALARIA [Binax, Seattle,
WA] and CARESTART ™, [Accessbio, Monmouth Junction,
NJ]) were used in this study to detect the circulating Plas-
modium antigen in the whole blood for the diagnosis of
malaria. Both of the ICTs detect the Plasmodium falci-
parum-specific HRP2 antigen as well as a panmalarial anti-
gen common to all Plasmodium species (aldolase in the
case of BINAXNOW and pLDH in the case of CARE-
START). The assays were performed according to the man-
ufacturer's instructions. The test results were
independently examined and interpreted by three blinded
observers (one of whom was not a trained medical labo-
ratory technologist). The final results of the test were
recorded as either negative or positive based on the major-
ity agreement. While ICT results reported here were on
fresh frozen specimens,, all specimens were frozen only
once, kept under monitored refrigerator conditions
according to Clinical Laboratory Improvement Amend-
ments (CLIA) guidelines. No difference was seen between
single frozen and fresh frozen specimens when tested by
ICT.
Multiplex real-time quantitative polymerase chain 
reaction (QPCR)
DNA was extracted from 100 μl of thawed EDTA-whole
blood using the QIAamp DNA Mini Kit (Qiagen, Valen-
cia, CA) according to the manufacturer's instructions. The
extracted DNA was stored at -20°C in sterile capped con-
tainers until used. The qPCR was performed by using
primers and reaction conditions described previously by
Alberta Public Health Laboratory with the following mod-
ifications: fluorophores for probes of P. facliparum were
changed to FAM-MGBNFQ and P. vivax to VIC-MGBNFQ
[12]. Briefly, qPCR was performed under standard condi-
tions (1 cycle of 50°C for 2 mins; 1 cycle of 95°C for 10
mins; 45 cycles of 95°C for 15 s and 60°C for 1 min) with
the ABI TaqMan 7900 (Applied Biosystems Inc, Foster
City, CA). The reaction was performed with a final volume
of 25 μl containing 5 μl of template DNA, 12.5 μl of Taq-
Man universal master mix (ABI), and 7.5 μl of pooled
primers and probes mix. Samples were confirmed Plasmo-
dium positive with genus-specific primers Plasmo1 and
Plasmo2 and the Plasprobe to detect a region of the Plas-
modium 18S gene that is conserved across all five species.
The Plasmodium species present in the sample were deter-
mined with species-specific forward primers, Plasmo2
and species-specific probes. The reaction was performed
by multiplexing two plasmodium species in a single tube
with distinct fluorophores for each probe, e.g. P. falci-
parum/P. vivax in a one tube and P. malariae/P. ovale in
another tube. A cutoff of 40 cycles was used to define pos-
itive samples [12]. The test panel also included a number
of controls: negative sample extraction as a negative con-
trol, β2-macroglobulin target amplification as a positive
extraction control for the specimen, a positive reference
control to detect any variation between runs, and no tem-
plate negative controls for each of the master mixes.
Quality assurance
QPCR results were also compared with another reference
provincial laboratory for public health, Edmonton,
Alberta, Canada, using a blinded panel of 10 randomly
selected blood specimens as part of quality assurance. The
10 blinded panel of blood specimens included P. vivax (n
= 3), P. falciparum (n = 3), P. ovale (n = 3), mixed infection
of P. falciparum and P. malariae (n = 1), and negative (n =
1). Microscopists used in this study are part of the INSPQ
blood parasitology, quality assurance programme.
Limit of detection (LOD) for clinical isolates
To determine the minimum number of Plasmodium para-
sites detectable by two ICTs and QPCR, blood samples
from twelve patients infected with P. falciparum (n = 3), P.
vivax (n = 3), P. malariae (n = 3), and P. ovale (n = 3) were
collected. The DNA purified from serial dilutions was per-
formed in triplicate by QPCR. The ICTs were performed in
parallel on all the blood sample serial dilutions, the
results were interpreted by two different readers. The
microscopy on serial dilutions was ruled out because the
blood samples were already stored at -20°C in the malaria
bio-repository. In addition, a LOD study was also done
prospectively from three patients who from the Demo-
cratic Republic of Congo and were positive for P. falci-Malaria Journal 2009, 8:284 http://www.malariajournal.com/content/8/1/284
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parum by reference microscopy. To establish the ability of
assays like ICT and QPCR to detect only the gametocyte
stage of Plasmodium  parasite, blood sample from one
patient exclusively infected with P. falciparum gametocyte
stage was used. All the blood samples were subjected to
serial dilution with uninfected erythrocytes from healthy
individuals with known baseline erythrocyte counts. The
DNA purified from the dilutions was treated in triplicates
for QPCR assay.
Limit of detection (LOD) for laboratory strains
The P. falciparum 3D7 strain was grown in two sets in
human Rh+ erythrocytes at a haematocrit level of 5% in
complete RPMI 1640 medium in tissue culture flasks (25
cm2 and 75 cm2) according to the method of Trager and
Jensen [16]. The culture flask was replenished with a fresh
batch of medium every 24 hours, and the culture was rou-
tinely monitored through Giemsa-staining of thin smears.
The P. falciparum culture was synchronized to get only ring
stages of P. falciparum as described earlier using 5% D-
sorbitol [17]. The parasitaemia in the synchronized cul-
ture was determined from Giemsa-stained thin smears. In
these malaria cultures to express the parasitaemia as
number of parasites present in 1 μl of culture, the RBC/μl
was counted using a standard Neubauer haemocytometer
as per the manufacturer's instructions. The two sets of syn-
chronized cultures were subjected to tenfold serial dilu-
tion with uninfected erythrocytes from healthy
individuals. The DNA purified from the dilutions was per-
formed in triplicates for QPCR assay. The microscopy and
ICTs were performed in parallel on all the serial dilutions,
the results were interpreted by two different readers.
Quantitating parasitaemia and ribosomal (r) DNA copy 
number from frozen specimens, fresh isolates, and 
laboratory strains
In frozen blood specimens to express the parasitaemia as
number of parasites present in 1 μl of blood, it was
assumed that 1 μl of blood contained 5 × 106 red blood
cells, so 1% parasitaemia corresponds to 1 parasitized red
blood cell/100 red blood cells or 50,000 parasites/μl of
blood [18]. In the three fresh blood specimens to express
the parasitaemia as number of parasites present in 1 μl of
blood, the RBC/μl was calculated using a standard Neu-
bauer haemocytometer as per the manufacturer's instruc-
tions. Infected blood samples were diluted with
uninfected erythrocytes from healthy individuals with
known baseline erythrocyte counts. Tenfold serial dilu-
tions were made for each blood sample. The stage specific
parasitaemia proportion was identified by a microscopist
into different stages, such as single ring, double rings, tri-
ple rings, growing trophozoites, immature trophozoites,
mature trophozoites, gametocytes, mature schizonts, and
immature schizonts. The QPCR was performed on the
ten-fold dilutions of these blood samples.
The rDNA copy number was calculated by using the fol-
lowing formula: rDNA copy number/reaction = (number.
of parasitized RBC/μl)* ploidy * genecopy *5. The actual
parasite ploidy number was determined as describes else-
where [19]. Briefly, the ploidy for various stage of malarial
parasites like, single ring and growing trophozoites was 1;
double ring and gametocytes was 2; immature tropho-
zoite, mature schizont and immature schizont was 8; and
mature trophozoite was 16. The average rDNA gene copy
number per parasite was considered as 6. A factor of 5 was
multiplied, which accounts for the loading volume of
DNA template per reaction.
Statistical data analysis
Sensitivity was calculated as follows: number of true pos-
itives divided by number of true positives plus false nega-
tives × 100. Specificity was calculated as follows: number
of true negatives divided by the number of true negatives
plus false positives × 100. Separate analyses were con-
ducted using reference microscopy and QPCR as gold
standards. To determine the statistical significance of the
results, the confidence interval (CI) and the margin of
error for the sample size were determined [20]. The inter-
reader variability was calculated by applying Kappa statis-
tic [21].
Results
Comparison of microscopy, ICTs, and RTPCR
Evaluation of the sensitivity and specificity of microscopy,
BINAXNOW, and CARESTART using QPCR and micros-
copy separately as the gold standard was carried out
(Table 2). The microscopy was found to have higher sen-
sitivity and specificity than the ICTs. The sensitivity of
CARESTART (85.2%) was higher than BINAXNOW
(83.67%), and both the ICTs had similar specificities
(99.26%). The discordant results of microscopy, ICTs, and
QPCR are summarized in Table 3. Among 466 patients in
whom malaria was suspected, 170 (36.5%) were positive
by microscopy. The remaining 296 samples were negative.
Microscopy was used as the reference standard for com-
parison with the other methods. The CI for the sample
size of 466 was 95% and the margin of error was 4.49%.
The BINAXNOW detected malaria parasites in 166 of 170
microscopically positive samples with a sensitivity of
86.47% (95% confidence interval [CI] 81.98-90.96). The
CARESTART detected malaria parasites in 169 of 170
microscopically positive samples with a sensitivity of
88.24% (95% CI 83.75-92.73). Among the 296 samples
that were negative by microscopy, both ICTs detected
malaria parasites in 19 samples with a specificity of
93.58% (95% CI 89.09-98.07). The QPCR detected
malaria parasites in 169 of 170 microscopically positive
samples with a sensitivity of 99.41% (95% CI 94.92-100).
The QPCR detected malaria parasites in 27 of 296 micro-
scopically negative samples with a specificity of 90.88%Malaria Journal 2009, 8:284 http://www.malariajournal.com/content/8/1/284
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(95% CI 86.39-95.37). Out of these 27 QPCR positive but
microscopy negative samples, 17 were also positive by
ICTs. Ten samples were exclusively positive by QPCR and
negative by microscopy and ICTs. The QPCR was negative
in one out of 170 microscopically positive samples; this
sample was also negative by ICTs. The QPCR has highest
sensitivity (99.41%) in comparison to BINAXNOW
(86.47%) and CARESTART (88.24%).
Conventional microscopy
A total of 170 out of 466 blood samples screened were
positive for Plasmodium spp by microscopy. These 170
microscopy positive included 82 positive for P. falciparum,
63 positive for P. vivax, one positive for P. ovale, two pos-
itive for P. malariae, two positive for P. falciparum + P. ovale
(mixed), one positive for P. falciparum + P. vivax (mixed),
one positive for P. falciparum + P. malariae (mixed) and 18
positive for Plasmodium spp (species remained undeter-
mined). 296 blood samples were negative for Plasmodium
spp by microscopy. Microscopy was used as the reference
standard for comparison with the other methods.
Immuno-chromatographic tests (ICT)
The BINAXNOW was positive for Plasmodium spp in
35.6% (166 out of 466) blood samples. These 166
BINAXNOW positive included 84 positive for P. falci-
parum/mixed Plasmodium species, 23 positive for P. falci-
parum, 59 positive for non P. falciparum species. The
CARESTART was positive for Plasmodium spp in 36.3%
(169 out of 466) blood samples. These 169 CARESTART
positive included 84 positive for P. falciparum/mixed Plas-
modium species, 22 positive for P. falciparum, 63 positive
Table 2: Sensitivity and specificity expresessed as perecentarge of microscopy and ICTs (BINAXNOW and CARESTART) as 
alternately compared to QPCR and microscopy as gold standard method.
Assay type QPCR Microscopy
Sensitivity Specificity Sensitivity Specificity
Microscopy 86.22 99.63 NA* NA
BINAXNOW 83.67 99.26 86.47 93.58
CARESTART 85.2 99.26 88.24 93.58
QPCR NA NA 99.41 90.88
* NA - Not Applicable
Table 3: Discrepant analysis of different assays for the laboratory diagnosis of malaria based on results of QPCR.
Species Microscopy & 
BINAXNOW 
& 
CARESTART 
Positive
Microscopy & 
BINAXNOW 
& 
CARESTART 
Negative
Microscopy 
& 
BINAXNO
W Positive
Microscopy 
& 
CARESTAR
T Positive
BINAXNO
W & 
CARESTAR
T Positive
Only 
Microscopy 
Positive
Only 
BINAXNO
W Positive
Only 
CARESTA
RT Positive
Pf 85 4 1 2 16 2 0 1
Pv 54 5 0 3 0 10 0 0
Pm 110 0 0 1 0 0
Po 100 0 0 4 0 0
Pf & Pv 300 0 0 0 0 0
Pm & Po 001 0 0 0 0 0
Pf & Pm 100 0 0 0 0 0
Negative 02 6 6 0 0 2 1 1 0
Total 145 276 2 5 18 18 1 1Malaria Journal 2009, 8:284 http://www.malariajournal.com/content/8/1/284
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for non P. falciparum species. The Kappa value of inter-
reader variability among three readers for BINAXNOW
and CARESTART was calculated to be 0.872 and 0.898
respectively.
Multiplex-QPCR
The QPCR was positive for Plasmodium spp in 42.1% (196
out of 466) of blood samples. These 196 RTPCR positive
included 111 positive for P. falciparum, 72 positive for P.
vivax, five positive for P. ovale, three positive for P. malar-
iae, one positive for P. malariae + P. ovale (mixed), and
three positive for P. falciparum + P. vivax (mixed), one pos-
itive for P. falciparum + P. malariae (mixed). The result of
multicentre validation of RTPCR on a blinded panel of 10
randomly selected blood specimens demonstrated 100%
concordance. A different blinded panel was forwarded to
the Alberta provincial reference laboratory, where 100%
concordance was also achieved. This process was repeated
six months later with a different blinded panel with 100%
agreement as part of an ongoing quality control proce-
dure. However, the comparative results of the multicentre
validation showed that the Ct values were slightly lower
than that performed by Alberta (see Additional File 1). All
four  Plasmodium  species were successfully differentially
detected in the species specific multiplex QPCR reaction.
Limit of detection analyses
The ability of QPCR to be quantitative was established by
the comparison between the log of parasitaemia versus Ct
value (threshold cycle) for all the four species of malaria.
This was evaluated on representative clinical specimens
for all four species of P. falciparum (n = 3), P. vivax (n = 3),
P. malariae (n = 3), and P. ovale (n = 3). An increasing par-
asite concentration was reflected by lower Ct value with
good linear correlation for both clinical isolates of all spe-
cies (Figures 1, 2, 3, 4 and 5). To establish the minimum
copy number of the target rDNA gene sequence detectable
by QPCR, DNA from blood specimen exclusively positive
for P. falciparum single ring stage was used. The standard
curve for QPCR was constructed by using 10-fold serial
dilutions of genomic DNA (115800 to 0.01158 rDNA
copies/μl). A plot of rDNA copy number versus the Ct
value is shown in Figure 6A. The detection limits was
found to be 11 rDNA copies/μl for P. falciparum. A plot of
the Ct versus the log of rDNA copy/μl showed a linear cor-
relation (R2 = 0.9746). An amplification plot generated by
QPCR for the 10-fold serial dilutions of P. falciparum
rDNA is depicted in Figure 6B.
The comparative results of limit of detection showed that
the QPCR had the highest sensitivity to detect parasite at
lower levels (higher dilutions) as compared to microscopy
and ICTs. For the three frozen biological replicates each of
P. falciparum, P. vivax, P. malariae and P. ovale, there was
an average log dilution difference of 2, 3, 4, and 4 respec-
tively between QPCR and ICTs (Table 4). Similary, for the
three fresh biological replicates of P. falciparum there was
an average log dilution difference of 1 between QPCR and
ICTs and an average log dilution difference of 2 between
QPCR and Microscopy (Table 4). In order to understand
the effect of different malarial parasite stage proportion
on the QPCR detection system, a detailed evaluation of
the various stages of malarial parasite and its contributing
rDNA copy number for the LOD was also done (Table 5).
For P. falciparum, detection of single ring infections
required a higher rDNA copy number than double ring
infections, and detection of gametocytes by QPCR
required a higher rDNA copy number than for other Plas-
modium spp. For non-P. falciparum species, detection of
trophozoites required a higher rDNA copy number than
ring stages.
Discussion
Performance characteristics, limit of detection, inter-
reader variability and cost of QPCR, two ICTs
(BINAXNOW and CARESTART) and reference microscopy
was evaluated. QPCR quality assurance was sought by
comparing the results of QPCR in two distinct reference
lab settings. The results indicate that the QPCR is the most
analytically sensitive method (sensitivity 99.41%), fol-
lowed by CARESTART (sensitivity 88.24%), and
BINAXNOW (sensitivity 86.47%) for the diagnosis of
malaria in returning travelers when compared to micros-
copy. The results of the comparative LOD study between
different assays suggest that the QPCR has the superior
LOD. Microscopy was unable to specifically identify Plas-
modia spp. in 18 out of 170 positive samples by QPCR.
Moreover, the 17 samples that were negative by micros-
copy and positive by QPCR were also positive by ICTs.
Although microscopy can be sensitive to a threshold of 5-
50 parasites/μl depending on the expertise of the micro-
scopist, the average microscopist is likely to achieve a sen-
sitivity closer to 100 parasites/μl or higher [22,23]. The
possible explanation for the discordance in these samples
could be the inability of microscopy to appreciate the
degraded parasite, merozoites stage, sequestered parasites
in the splenic vasculature, or the occult exo-erythrocytic
schizogony stage. More likely, the LOD studies suggest
that reference microscopy is unable to detect parasites
when below a certain threshold. Interestingly, this study
revealed that the limit of detection was significantly
affected by the stage of malarial parasite. For example, the
two P. malariae positive specimens "Pm1" and "Pm3" (see
Table 4) had the same parasitaemia of 0.06%, but there
was a marked difference of ten fold in the limit of detec-
tion. This may be due to the difference between the para-
site stage proportions between the specimens. The
specimen "Pm1" had higher proportion of parasite stages
like growing trophozoites and mature trophozoites inMalaria Journal 2009, 8:284 http://www.malariajournal.com/content/8/1/284
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A plot of log of parasitaemia versus threshold cycle for the 10-fold serial dilutions of P. falciparum (A) and a representative  amplification plot for 10-fold serial dilutions (B) generated by QPCR are also shown Figure 1
A plot of log of parasitaemia versus threshold cycle for the 10-fold serial dilutions of P. falciparum (A) and a 
representative amplification plot for 10-fold serial dilutions (B) generated by QPCR are also shown. All clinical 
isolates were amplified in triplicate for each species with the linear correlation coefficient (R2) shown in the corresponding 
color.
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A plot of log of parasitaemia versus threshold cycle for the 10-fold serial dilutions of P. vivax (A) and a representative amplifica- tion plot for 10-fold serial dilutions (B) generated by QPCR are also shown Figure 2
A plot of log of parasitaemia versus threshold cycle for the 10-fold serial dilutions of P. vivax (A) and a repre-
sentative amplification plot for 10-fold serial dilutions (B) generated by QPCR are also shown. All clinical isolates 
were amplified in triplicate for each species with the linear correlation coefficient (R2) shown in the corresponding color.
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A plot of log of parasitaemia versus threshold cycle for the 10-fold serial dilutions of P. malariae (A) and a representative ampli- fication plot for 10-fold serial dilutions (B) generated by QPCR are also shown Figure 3
A plot of log of parasitaemia versus threshold cycle for the 10-fold serial dilutions of P. malariae (A) and a rep-
resentative amplification plot for 10-fold serial dilutions (B) generated by QPCR are also shown. All clinical iso-
lates were amplified in triplicate for each species with the linear correlation coefficient (R2) shown in the corresponding color.
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A plot of log of parasitaemia versus threshold cycle for the 10-fold serial dilutions of P. ovale (A) and a representative amplifica- tion plot for 10-fold serial dilutions (B) generated by QPCR are also shown Figure 4
A plot of log of parasitaemia versus threshold cycle for the 10-fold serial dilutions of P. ovale (A) and a repre-
sentative amplification plot for 10-fold serial dilutions (B) generated by QPCR are also shown. All clinical isolates 
were amplified in triplicate for each species with the linear correlation coefficient (R2) shown in the corresponding color.
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A plot of log of parasitaemia versus threshold cycle for the 10-fold serial dilutions of P. falciparum laboratory strain 3D7 (A) and  a representative amplification plot for 10-fold serial dilutions (B) generated by QPCR are also shown Figure 5
A plot of log of parasitaemia versus threshold cycle for the 10-fold serial dilutions of P. falciparum laboratory 
strain 3D7 (A) and a representative amplification plot for 10-fold serial dilutions (B) generated by QPCR are 
also shown. All clinical isolates were amplified in triplicate for each species with the linear correlation coefficient (R2) shown 
in the corresponding color.
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A plot of rDNA copy number versus the threshold cycle for the 10-fold serial dilutions of P. falciparum specific QPCR (A) with  the rDNA copy number in parentheses Figure 6
A plot of rDNA copy number versus the threshold cycle for the 10-fold serial dilutions of P. falciparum specific 
QPCR (A) with the rDNA copy number in parentheses. The amplification plot generated by QPCR for 10-fold serial 
dilutions of P. falciparum rDNA is also shown (B).
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Table 4: Comparative LOD results of Microscopy, ICTs and RTPCR performed on blood specimens from representative (n = 3 per 
species) patient specimens for each malaria species.
Species % Parasitaemia Distribution Microscopy BINAXNOW CARESTART QPCR
P. falciparum 1 Parasitaemia 5.6%
88.2% Single Rings 1.00E-03 1.00E-04 1.00E-03 1.00E-05
11.8% Double Rings
P. falciparum Parasitaemia 0.6%
100% Single Rings 1.00E-02 1.00E-03 1.00E-03 1.00E-04
P. falciparum 3 Parasitaemia 22.1%
86.8% Single Rings 1.00E-02 1.00E-04 1.00E-04 1.00E-05
13.2% Double Rings
P. vivax 1 Parasitaemia 0.474%
19.1% single rings ND 1.00E-01 1.00E-02 1.00E-05
57.4% growing trophozoites
19.1% mature trophozoites
4.2% gametocytes
P. vivax 2 Parasitaemia 0.728%
54.7% rings ND 1.00E-01 1.00E-02 1.00E-05
45.3% growing trophozoites
P. vivax 3 Parasitaemia 0.061%
70% growing trophozoites ND 1.00E+00 1.00E-01 1.00E-03
15% mature trophozoites
15% gametocytes
P. malariae 1 Parasitaemia 0.06%
25% growing trophs ND 1.00E+00 1.00E+00 1.00E-04
57.1% mature trophs
3.6% mature schizonts
7.1% immature schizonts
7.1% gametocytes
P. malariae 2 Parasitaemia 0.10%
11.1% rings ND 1.00E+00 1.00E+00 1.00E-04
50% growing trophozoites
13.9% mature trophozoites
2.8% immature schizonts
5.6% mature schizonts
16.7% gametocytes
P. malariae 3 Parasitaemia 0.0614%
11.1% rings ND 1.00E+00 1.00E+00 1.00E-03
44.4% growing trophozoites
14.8% immature schzionts
11.1% mature trophozoites
18.5% gametocytes
P. ovale 1 Parasitaemia 0.167%
3% rings ND undetectable 1.00E+00 1.00E-04
94% growing trophozoites
3% mature schizonts
P. ovale 2 Parasitaemia 0.219%
11.4% rings ND 1.00E+00 1.00E+00 1.00E-05
85.7% growing trophozoites
2.8% gametocytes
P. ovale 3 Parasitaemia 0.009%
100% growing trophozoites ND undetectable undetectable 1.00E-03
Values reflect the tenfold dilution level from the original sample.
ND- not determined due to lack of unfrozen specimens for these species.Malaria Journal 2009, 8:284 http://www.malariajournal.com/content/8/1/284
Page 14 of 17
(page number not for citation purposes)
comparison to "Pm3". Our QPCR appeared to be more
sensitive in the detection of the malarial parasite in blood
specimens than performed by our comparator institution
in Alberta (see Additional file 1). This is likely because of
the difference in the number of targets amplified in one
tube. The QPCR screens two targets in one tube as
opposed to four targets in Alberta. This suggests that the
PCR reaction kinetics favours the lesser number of targets
per reaction due to competition among the targets for
amplification. Of note, this marginal difference did not
affect result interpretation.
It has been reported that the sensitivity of ICT to detect
malarial parasites decreases as the parasitaemia decreases
[24]. False-negative results, particularly for P. falciparum
with its more virulent natural history of infection, are of
concern. For BINAXNOW four false-negative results
occurred for P. falciparum infections, 13 for P. vivax, four
for P. ovale, and one for P. malariae. For CARESTART, three
false-negative results occured for P. falciparum infections,
10 for P. vivax, four for P. ovale, one for P. malariae and one
for a P. ovale and P. malariae mixed infection. In most
cases the false negative results were due to low parasitae-
mia, but in a very few cases the false negative results was
even at high parasitaemia. This may be attributed to the
prozone phenomenon (antibody excess) making antigen
unavailable to be detected by ICT or a possible mutant
gene resulting in altered HRP-2 antigen [24]. The sensitiv-
ity of CARESTART (85.2%) was slightly higher than
BINAXNOW (83.67%), and both ICTs had similar specif-
icities (99.26%). CARESTART sensitivity was higher
because it was able to pick up non-falciparum species on
more occasions than BINAXNOW, this suggests that Plas-
modium  lactate dehydrogenase (pLDH) used in CARE-
START is a more sensitive marker than aldolase used in
BINAXNOW for detecting non-falciparum species. In the
majority of samples, both the ICTs have identified P. falci-
parum  monoinfections (detected by microscopy and
QPCR) as P. falciparum/mixed because both bands (P. fal-
ciparum  and pan-malarial) were positive, thereby not
allowing the technologist to rule out mixed infection on
the basis of the ICT alone. The sensitivity of both ICTs for
the detection of only P. ovale and P. malariae infections
was 0% and 50% respectively.
Previous reports suggest that the expression levels of the
pan-Plasmodium antigen (LDH and aldolase) in P. ovale
and P. malariae may be minimal and this in combination
with low parasitaemia in these infections accounts for rel-
atively lower sensitivity for the detection of these malaria
species [25,26]. It is important to note that both the ICTs
have the limitation that does not distinguish between the
non-P. falciparum species (P. vivax, P. ovale, and P. malar-
iae), nor can it reliably distinguish pure P. falciparum
infections from mixed falciparum infections. However, the
test was found to be simple to conduct, rapid, and easy to
interpret, with excellent inter-reader agreement for
BINAXNOW and CARESTART as K value = 0.872 and K
value = 0.898 respectively, indicating good agreement
between trained and non-trained readers. Discrepancies
between readers occurred mainly when the test result was
weakly positive (faint band), especially in cases of low
parasitaemia. Rapid diagnostic assays like ICTs may be a
useful tool when expert microscopy is not available or
onsite field survey is to be conducted on large population.
Considering the inherent limitation and advantages of all
the assays evaluated in the present study and the evidence
from previous reports, ICTs are a useful diagnostic tool
and can be used as an adjunct to conventional microscopy
in front-line clinical laboratories in areas where malaria is
Table 5: Average stage-specific detection limit of clinical specimens (n = 3 per species) by QPCR. 
Parasite stage specific limit of detection
rDNA copy number per reaction (parasites per reaction)
Single Rings Double Rings Growing 
Trophozoites
Mature 
Trophozoites
Gametocytes Mature 
Schizonts
Immature 
Schizonts
P. falciparum 6.21 ± 2.0
(1.08 ± 0.34)
1.74 ± 1.09 
(0.29 ± 0.18)
30
(5)
P. vivax 3.66 ± 2.3
(0.60 ± 0.4)
4.51 ± 0.4
(0.75 ± 0.07)
21.72
(3.6)
0.590
(0.098)
P. malariae 5.90 ± 4.29 
(0.95 ± 0.75)
4.74 ± 2.490 
(0.78 ± 0.415)
82.2
(13.7)
3.03 ± 1.7
(0.5 ± 0.3)
4.475 ± 1.9
(0.705 ± 0.2)
4.15 ± 0.94 
(0.69 ± 0.16)
P. ovale 0.56 ± 0.18 
(0.08 ± 0.02)
18 ± 4.5
(3 ± 0.75)
0.18
(0.03)
6
(1)
LOD are stated as either ribosomal DNA copy number or parasites per reaction with standard error where multiple stages were present in 
specimens.Malaria Journal 2009, 8:284 http://www.malariajournal.com/content/8/1/284
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not endemic. These laboratories frequently lack sufficient
specimen volume to maintain expertise in diagnostic
microscopy. A rapid diagnostic test like ICT could provide
a fast although still preliminary diagnosis, while results
are confirmed from a reference laboratory. There were
three false-positive BINAXNOW results and two false-pos-
itive CARESTART results in this study. Occasional false-
positive results due to the presence of rheumatoid factor
have previously been reported with diagnostic methods
based on the detection of HRP II [27]. It is important to
note that, due to the incidental false-negative results with
ICTs, malaria infection cannot be ruled out on the basis of
a negative ICT result. Reference-level microscopy remains
essential especially with the capability for species identifi-
cation, parasite quantitation, and capacity to rule out
gametocyte only infections. However, due to its excellent
LOD, QPCR at the reference level serves the essential pur-
pose of confirming or refuting microscopic speciation in
certain cases (discussed below). A limitation of QPCR and
ICT was that a positive result was obtained in one blood
specimen with pure P. falciparum gametocytes. This shows
that the QPCR can be positive in convalescence or clini-
cally cured infections due to persistent sexual-stage forms
(gametocytes) implying that the QPCR is unable to distin-
guish gametocyte only infections from true infections.
The cost and the processing time for all the four tech-
niques employed for the laboratory diagnosis of malaria
were evaluated (Table 6). At the time of writing, when
purchased in bulk, the BINAXNOW kit was priced at
US$5.20 per sample, whereas the CARESTART™ Malaria
was priced at US$1.20 per sample. Of note, no significant
difference was observed in this study between either ICT
in spite of the cost differential. The BINAXNOW test has
the approval from regulatory bodies in North America,
such as the Food and Drug Administration and Health
Canada. Reference microscopy of thick and thin smears
costs US$2.50 for reagents in our reference laboratory set-
ting. The ABI 7900HT Fast Real-Time PCR System used
here for QPCR had a per sample cost of US$14.80 for rea-
gents. Of note, QPCR requires a one time capital equip-
ment purchase of the thermocycler. For example, the
FC2500 SmartCycler System (Cepheid, Sunnyvale. CA)
costs approximately US$36,000 and is capable of 14 reac-
tions per run which seems appropriate given the fre-
quency of malaria requests and the "stat" nature of the test
in a non-endemic setting. The cost analysis clearly showed
that the CARESTART was the cheapest method. While
ICTs do not require trained staff, reference parasitology
laboratories continue to place emphasis on microscopy
training. A challenge to staffing of QPCR is the lack of
equivalent training in molecular techniques. This is in
contrast to virology and bacteriology sections where cross-
training in molecular techniques is now common place in
the reference laboratory.
Conclusion
Taken together, QPCR should be implemented in all ref-
erence clinical laboratories and used in specific scenarios:
(i) when a clinician does not agree with microscopic find-
ings based on clinical pre-test probability of malaria; (ii)
when two microscopists disagree on the findings particu-
larly in cases of mixed infection, low parasitaemia, and
sample degradation; (iii) when a microscopist does not
visualize enough parasite stages to make a speciation call.
Of note, the significance of a positive QPCR result follow-
ing pharmacotherapy is still unclear as it could represent
a fully treated infection with only DNA present and no
Table 6: Comparison of the cost of different techniques employed for the diagnosis of malaria
Reagents Microscopy BINAXNOW CARESTART QPCR
QIAmp
DNA Extraction
NA NA NA $2.30
TaqMan
master mix and probe
NA NA NA $3.00
BINAXNOW NA $5.00 NA NA
CARESTART NA NA $1.00 NA
Consumables $2.50 $0.20 $0.20 $9.50
Total cost * $2.50 $5.20 $1.20 $14.80
Approximate technologist time # 90 mins 30 mins 30 mins 45 mins
* These are approximate cost estimates are in United States Dollars; it does not include tax and shipping
# Technologist time is restricted to hands-on time with sample preparation and testingMalaria Journal 2009, 8:284 http://www.malariajournal.com/content/8/1/284
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live asexual stage organisms. As such, use of QPCR for test
of cure is not encouraged until further studies are availa-
ble. Due to the poor LOD with non-P. falciparum species
and lack of advantage in diagnostic sensitivity when com-
pared to reference microscopists for P. falciparum, the ICTs
appear better suited to the community or hospital labora-
tory where experience with malaria smears may be limited
and thus confer a diagnostic advantage.
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